European Commission Related Content
EU allocates additional €500 million to COVAX facility
The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
European Commission approves second Moderna contract for 300m vaccines
The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
Commission launches “HERA Incubator” project to fight COVID mutations
The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
The Johnson & Johnson COVID vaccine works with just one dose
The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.
The Habsburg Empire: Is the nation-state national and the empire imperial?
Gábor Egry, Director-General at the Institute of Political History and principal investigator of Horizon 2020 funded project NEPOSTRANS, dissects the ideologies that shaped and outlived the Habsburg Empire.
European Commission presents Europe’s Beating Cancer Plan
The European Commission has announced its Europe's Beating Cancer Plan which sets out a new EU approach to cancer prevention, treatment and care.
European Commission pays out €14 billion under the SURE programme
The European Commission has allocated €14 billion to nine Member States under the Support to mitigate Unemployment Risks in an Emergency (SURE) programme.
The EU authorises AstraZeneca COVID vaccine for use
European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.
Is this a vaccine war or the first post-Brexit war?
Right now, the rift between AstraZeneca and the European Commission continues to grow - but is it a vaccine war or the first post-Brexit war?
AstraZeneca CEO discusses the European Commission vaccine feud
AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.
Green paper explores challenges and opportunities of Europe’s ageing society
The European Commission has presented a green paper to launch a broad policy debate on the challenges and opportunities of Europe's ageing population.
European Commission approves second IPCEI on batteries
The European Commission has given the green light on the second Important Project of Common European Interest (IPCEI) in the field of batteries.
BlueInvest fund gives €45 million to food security projects
The BlueInvest fund today allocated the first of an available €75 million to two projects working against food insecurity - announcing the names at a BlueInvest Day event.
European Commission to create “transparency mechanism” for vaccine exports
In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.
European Commission launches new Green Consumption Pledge
The European Commission has launched its new Green Consumption Pledge, the first initiative delivered under the New Consumer Agenda.
European Commission will get 60% less AstraZeneca vaccines
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
European Commission outlines key actions to beat COVID-19
The European Commission has set out the key actions needed to step up the fight against the COVID-19 pandemic.
Why energy is at the heart of the EU’s decarbonisation efforts
Kadri Simson, EU Energy Commissioner, discusses why the EU has placed energy and the heart of its decarbonisation efforts.
EU finalises talks with Valneva to secure a new vaccine
Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.
European Commission gives 24 grants to COVID-19 plasma projects
The projects will happen in 14 Member States and the United Kingdom, with 36 million in funding to get COVID-19 plasma to patients - boosting their immune response to the virus.